PPARGC1A and age-related macular degeneration: Surprisingly, in combination (P+Q) treatment significantly increases PGC-1α expression levels in the Glc cybrids (4.85-fold, ±0.75, p-value = 0.032), while it increases expression levels in AMD cybrids but did not reach a statistically significant level (Figure 3a).